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S U M M A R Y
Objectives: The aim of this study was to investigate the genetic diversity in the stem-loop (SL) IV sub-
domain of the human rhinovirus (HRV) internal ribosomal entry site (IRES), which plays key roles in the
initiation of viral translation by host protein interaction.
Methods: The primary SL-IV sequences of 194 HRVs, consisting of 97 reference strains and 97 clinical
isolates, including the IRES sub-domains SL-IVa, SL-IVb, SL-IVc, and SL-IVd, were analyzed using
Lasergene, MEGA 4, and WebLogo. Additionally, secondary structures of SL-IV were predicted and
classiﬁed by RNAfold and CentroidHomfold-LAST.
Results: The predicted secondary structures of SL-IV showed variations in the position of bulbs, size of
the loop, and length of stems. SL-IVc had the most highly conserved nucleotide sequence, with structures
classiﬁed into two groups by the location of the poly(C) loop. Of the SL-IV sequences analyzed, 74
(79.56%) were classiﬁed in the major group and 19 (20.44%) in the minor group. Thirteen compensatory
substitution pairs of SL-IVc contributed to maintaining the stem structure.
Conclusions: This study showed that the IRES secondary structures of a large number of reference and
clinical HRVs were highly conserved, with several compensatory substitutions. It is expected that these
results will facilitate investigations into HRV function based on IRES secondary structures.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Human rhinoviruses (HRVs), members of the family Picornavir-
idae, were ﬁrst isolated in 1956. These viruses are 7200 nucleotides
in length and have a single-stranded, positive-sense RNA genome.
Recently, HRVs have been classiﬁed into HRV-A, HRV-B, and HRV-C
species, with 150 types of this virus proposed.1–6 HRVs are not only
the most common causative agents of mild upper respiratory tract
infections, but are also associated with more serious diseases,
including pneumonia and acute wheezing episodes associated
with bronchiolitis and acute asthma in children.7,8
At the canonical translation initiation site, eukaryotic mRNAs
have a 50 cap structure (methyl7 Gppp) that binds the eukaryotic
initiation factor eIF4E.9–12 However, some mRNAs, including both
cellular and viral, use a cap-independent translation initiation* Corresponding author. Tel.: +82 43 719 8223; fax: +82 43 719 8239.
E-mail address: youjin3693@gmail.com (Y.-J. Kim).
http://dx.doi.org/10.1016/j.ijid.2015.10.015
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).mechanism at the internal ribosome entry site (IRES).9,11,13–16
The IRES was ﬁrst identiﬁed in 1988 in poliovirus and
encephalomyocarditis virus (EMCV), also members of the Picorna-
viridae.13,16 Since then, other RNA viruses such as HRV, DNA viruses
including Kaposi’s sarcoma herpesvirus (KSHV), and cellular
mRNAs have been discovered to use IRES elements for transla-
tion.9,11,17 The picornavirus IRES is classiﬁed into four groups,
types I–IV, by sequence similarity and shared secondary RNA
structures. Each IRES type has three to seven stem-loops (SLs) in
the 50 non-coding region, and type I IRES, found in HRV and
enterovirus, has six SLs and one poly-pyrimidine tract (PPT)
located between SL-V and SL-VI.15,18–20 Translation initiated at the
picornavirus IRES is regulated by speciﬁc IRES-binding host
proteins.21 Upstream-of-Nras (Unr), a cytoplasmic RNA-binding
protein, was identiﬁed as a synergistic activator that binds the SL-V
and SL-VI region in HRV.22 The PPT-binding protein (PTB) that
binds to the PPT region and the poly(C) binding protein (PCBP) that
interacts with SL-IV are also known to be involved in alternative
splicing and translation.9,23–25ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
H. Kim et al. / International Journal of Infectious Diseases 41 (2015) 21–2822In this study, the detailed features of the HRV IRES-IV domain
were investigated; these have essential roles in HRV translation by
interacting with host proteins, thus the dimensional RNA
structures are especially important for functions among the other
IRES domains. The analysis of the sequences and predicted
secondary structures of IRES SL-IV in 97 reference strains and
97 clinical isolates of HRV are reported here.
2. Materials and methods
2.1. Ethics statement
This study was approved by the Institutional Review Board of
the Korea Centers for Disease Control and Prevention (KCDC; 2012-
09CON-03-4C) and the Yonsei University Health System Institu-
tional Review Board, Seoul, Korea (4-2008-0649). Patients who had
parental or legal guardian written consent to participate were
enrolled in a respiratory disease surveillance study. Participant
data were de-identiﬁed, except for age, sex, time of sample
collection, reported symptoms, and virus detection results, as
described previously.26
2.2. Specimen collection and sequencing of the HRV IRES
Nasal aspirate specimens from outpatients with an acute
respiratory tract infection (ARI, n = 3082) and nasopharyngeal
aspirate specimens from inpatients with a severe lower respiratory
tract infection (SLRI, n = 381) were collected from hospitals as part
of two surveillance systems, the Acute Respiratory Infections
Network (ARINET) and the SLRI surveillance system, in 2008–2009.
The ARINET surveillance system covers about 100 hospitals all over
Korea and patients of all ages. The SLRI surveillance system covers
four general hospitals in metropolitan areas and children aged less
than 5 years.26,27 Among the HRV-positive samples, including
827 from ARI and 85 from SLRI cases, selected viral RNAs were
ampliﬁed and sequenced using previously described methods.26 In
total, 44 ARI and 53 SLRI sequences were analyzed.Figure 1. Schematic representation of the RNA secondary structure of human rhinovirus
235–437, and SL-IVc was located within the SL-IV domain (nt 314–370, based on access
using RNAfold and CentroidHomfold-LAST.39–41.2.3. Nucleotide and phylogenetic analysis of SL-IV sequences
IRES SL-IV sequences (nt 235–437, based on HRV A41, accession
number DQ473491, as shown in Figure 1) of the 97 clinical isolates
and 97 reference HRVs were aligned, redundant sequences were
removed, and nucleotide percentage identity was calculated using
the ClustalW method in MegAlign (ver. 8.0.2(13.4)2) of the
Lasergene 8 program suite (DNAStar, Madison, WI, USA). The
phylogenetic tree of selected unique sequences of the 50 IRES SL-IVs
was estimated using the neighbor-joining method in MEGA 4 (ver.
4.0.2). Human enterovirus D68 (GenBank accession number
AY426531) was used as an outgroup.28 The pairwise identity
analysis was performed in stand-alone BLAST+. Then, an n  n
matrix of all pairwise identities was produced. The matrix was
plotted as a heat map using the default settings for heatmap.2 in
the gplots package of R (http://cran.r-project.org/web/packages/
gplots/index.html).29 The sequences were used to create a
WebLogo (http://weblogo.threeplusone.com) to examine nucleo-
tide conservation based on the height of a single letter nucleo-
tide.30
2.4. Prediction of RNA secondary structures in SL-IV
The secondary structures of 50 IRES SL-IV from clinical isolates
and reference HRVs were predicted by RNAfold in the Vienna RNA
package and by CentroidHomfold.31–33 With RNAfold, the default
option was used for dangling energies (‘-d2’), and lonely pairs in
the structure were disallowed with the ‘-noLP’ option. The
resulting secondary structures of a single sequence determined
by RNAfold were saved as an mfe (minimum free energy) structure.
To predict a single sequence secondary structure with Centroid-
Homfold, the user-speciﬁed RNA sequence option was used and
the database was compiled in the pipeline.
2.5. Nucleotide sequence accession numbers
The genome sequences of human rhinoviruses obtained from
clinical isolates that are described in this report have been (HRV) A41 IRES SL-IVc. The stem-loop SL-IV of the HRV-A41 IRES was located at nt
ion number DQ473491). The prediction of RNA secondary structure was performed
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KJ919951. Additional sequences have been reported previously
(GenBank accession numbers JX177617–JX177637).26
In addition, published reference sequences of 97 HRV included
in the analysis were obtained from GenBank (accession numbers
GQ323774, FJ445178, AY751783, L24917, M16248, NC009996,
X02316, DQ473486, DQ473488–DQ473494, DQ473497,
DQ473499, DQ473500, DQ473505–DQ473508, DQ473510,
DQ473511, DQ875932, EF173414, EF173415, EF173420,
EF173422, EF173423, EF173425, EF186077, EF582385–
EF582387, FJ445112, FJ445113, FJ445116, FJ445118–FJ445127,
FJ445129–FJ445136, FJ445138, FJ445141–FJ445147, FJ445149–
FJ445153, FJ445155–FJ445157, FJ445160–FJ445164, FJ445167,
FJ445177, FJ445179, FJ445180–FJ445183, and FJ445186–
FJ445190).
3. Results
3.1. SL-IVc is the most conserved region in the HRV SL-IV
The sub-domains of SL-IV, composed of SL-IVa (nt 235–281 and
nt 392–437), SL-IVb (nt 288–310), SL-IVc (nt 314–370), and SL-IVd
(nt 373–390), were analyzed (Figure 1). The average sequence
identity of the 194 SL-IV (nt 235–437) sequences was 71.65% and
the identities within the SL-IVa, SL-IVb, SL-IVc, and SL-IVd sub-
domains were 65.97%, 53.78%, 83.79%, and 55.99%, respectively.
Among the SL-IV domains, SL-IVc had the most highly conserved
primary sequence. The secondary structure of the SL-IV domain
was analyzed, as described in section 2.4., and it was determined
that the predicted secondary structure of SL-IVc was also highly
conserved, whereas SL-IVa, SL-IVb, and SL-IVd showed greater
variation in stem length, loop size, and small bulb number and
position.
To further characterize the secondary structures of SL-IVc, the
93 non-redundant representative sequences, consisting of 41 clini-
cal and 52 reference sequences, were selected for analysis. These
unique sequences showed a similar average identity (82.4%) to the
full SL-IVc domain, with nucleotide sequence identities ranging
from 57.9% to 98.2%. The secondary structures predicted in the
93 SL-IVc sub-domains alone were analyzed by two prediction
methods, RNAfold and CentroidHomfold-LAST, and the results
were compared. The predicted secondary RNA structures of SL-IVc
were highly conserved and consistent between methods. Only the
poly(C) loop had changed position by one nucleotide (Supple-
mentary Material, Supplementary ﬁle S1).
3.2. Two groups are deﬁned by the predicted secondary structures of
SL-IVc
Based on the location of the poly(C) loop, we assigned the SL-IVc
structures to one of two groups, with 74 (79.56%) sequences
assigned to the major group and 19 (20.44%) assigned to the minor
group (Supplementary Material, Supplementary ﬁle S2). The
poly(C) loop of the major group is found from nt 331 to 336, while
in the minor group, the poly(C) loop is located at nt 330 to 335 by
one nucleotide position shift (Figure 2). The HRV species
distribution, the ratio of severe symptom patients, and sequence
identity were compared, and identical patterns were found in the
two groups.
The 29 HRV-B strains (ﬁve clinical and 24 reference) identiﬁed
from the total 194 sequences (with 93 unique sequences) were all
found in the major group. However, the predicted secondary
structure of the other species, HRV-A and HRV-C, were found in
both groups, with no statistically signiﬁcant distinction. In all
97 clinical strains, the proportions of A and C species assigned to
the two groups, respectively, were 35 (49.3%) and 31 (43.7%) of71 total in the major group, and 10 (38.5%) and 16 (61.5%) of
26 total in the minor group. In addition, there was no statistically
signiﬁcant difference in the proportions of ARI (35 major and nine
minor) and SLRI (36 major and 17 minor) cases assigned to each
secondary structure group. ARI represented mild outpatient cases
and SLRI represented severe inpatient cases (Table 1).
The average sequence identities of the major and minor
structural groups were 83.5% and 84.1%, respectively. The SL-IVc
sequences resolved into several distinct clusters in the estimated
phylogenetic tree (Supplementary Material, Supplementary ﬁle
S2). To compare these clusters with the secondary structure-based
groups, a pairwise identity analysis of all 93 IRES SL-IVc sequences
was performed, and an n  n matrix of all pairwise identities was
plotted as a heat map (Figure 3). The dendrogram based on
hierarchical clustering showed sequence divergence in IRES SL-IVc
in spite of a conserved secondary structure. Therefore, it is
speculated that compensatory substitutions might play an
important role in maintaining the secondary structures of RNA
in the HRV sub-domain.
3.3. Compensatory substitutions in SL-IVc conserve RNA secondary
structure
Only 13 base pairs of predicted structures of SL-IVc had
compensatory substitutions out of all 22 base pairs in the stem
region, outside of the loop and bulge structure, as shown in
Figure 2. Among these 13 base pairs, AU pairs were the most
frequent base pairs, with 101 compensatory substitutions at ﬁve
AU pair positions. The compensatory substitution of UA pairs
had 43 compensatory substitutions at two positions. Two CG base
pairs and four GC base pairs had 26 and 39 compensatory
substitutions, respectively. The compensatory substitution of CG
and GC base pairs had 61 compensatory substitution events,
however for AU and UA base pairs there were 144 compensatory
substitution events, which was more frequent – almost twice that
of CG and GC, as shown in Table 2.
For all 93 sequences analyzed, nucleotide frequencies were
calculated for 26 compensatory nucleotide substitutions and
31 non-compensatory nucleotide substitutions, as shown in
Table 2. Any sequences containing gaps or missing data were
eliminated from the dataset (complete-deletion option). The
nucleotides A, U, C, and G in the compensatory substitutions were
found in similar proportions: 0.229 (adenine), 0.238 (uracil), 0.262
(cytosine), and 0.271 (guanine). However, among the non-
compensatory substitutions, C (0.328) and G (0.40) were more
frequent than A (0.129) and U (0.143). Purine and pyrimidine
frequencies were 0.500 (purine) and 0.500 (pyrimidine) in
compensatory substitutions, and 0.529 (purine) and 0.471
(pyrimidine) in non-compensatory substitutions, with no signiﬁ-
cant difference in the contribution of purines vs. pyrimidines to
these substitutions, as shown in Table 3.
3.4. Conserved nucleotides, a poly(C) loop, and a GNRA motif are
identiﬁed in the predicted secondary structures of HRV SL-IVc
The predicted RNA structures in the HRV SL-IVc had 17 con-
served nucleotides, one poly(C) loop, and one GNRA motif, in
addition to the 13 paired compensatory substitutions (Figure 2).
The conserved nucleotides were located at nt 315 (G), 319 (A), 320
(U), 321 (G), 323 (G), 324 (G), 325 (C), 356 (G), 357 (C), 358 (C), 361
(C), 362 (G), 363 (U), and 369 (C) of the paired stem region, whereas
360 (G), 364 (G), and 365 (G) were found in the bulge structure.
The poly(C) loop was located at nt 331–336 (major group) or nt
330–335 (minor group). In all sequences in the minor group, each
two nucleotides of two parts, located at nt 329–330 and 351–352,
were substituted for AC and GU, respectively. This differed from
Figure 2. Analysis of the predicted human rhinovirus (HRV) SL-IVc secondary structures. From the secondary RNA structure prediction of the HRV SL-IVc sub-domain, the
74 sequences in the major group (A) and the 19 sequences in the minor group (B) have 13 paired compensatory substitutions, 17 conserved nucleotides, one poly(C) loop
region, and one GNRA motif. All sequences of the minor group had conserved nucleotides AC and GU at nt 329–330 and 351–352, respectively.
H. Kim et al. / International Journal of Infectious Diseases 41 (2015) 21–2824the major group (Figure 2). The nucleotide frequencies (%) in the
poly(C) loop of the major and minor groups were 21.6 (U), 54.7 (C),
18.9 (A), 4.7 (G), and 21.1 (U), 56.1 (C), 20.2 (A), 2.6 (G),
respectively. The proportions of cytosine in the loop of the major
and minor group sequences were similar to each other and higherthan the other nucleotides. Speciﬁcally, two cytosines of the major
group (nt 335 and 336) and minor group (nt 334 and 335) were
conserved in spite of the shifting location of the loop.
A GNRA motif was also characterized, which was located from
nt 342 to 345 in the IRES SL-IVc of 93 unique sequences, as shown
Table 1
The distribution of species and clinical cases into human rhinovirus SL-IVc structural groups by nucleotide sequence analysis
Species Sequences analyzed Totalb (uniquec)
Clinical surveillance systems Reference
ARI LRI Totala
Major A 21 14 71 59 156 (74)
B 1 4 24
C 13 18 2
Minor A 4 6 26 7 38 (19)
B 0 0 0
C 5 11 5
Totalb (uniquec) 44 (21) 53 (20) 97 (52) 194 (93)
ARI, acute respiratory infection; LRI, lower respiratory infection.
a Clinical sequences, n = 97.
b Total sequences, n = 194.
c Unique SL-IVc sequences, n = 93.
Figure 3. The pairwise identities of 93 SL-IVc sequences in major and minor human rhinovirus (HRV) SL-IVc groups. This pairwise identity matrix was plotted using 93 unique
sequences. The color gradient of squares denotes an identity score, with the red color indicating an identity of 100% and the blue color representing a minimum identity of
56.1%. The closed and open circles indicate the major and minor structural groups. Clusters based on nucleotide identities were different from groups based on predicted
secondary structures of SL-IVc.
H. Kim et al. / International Journal of Infectious Diseases 41 (2015) 21–28 25
Table 2
The frequencies of compensatory substitutions in the SL-IVc stem region
Nucleotide base paira Positiona Number of compensatory substitutions by pair types Total
AU UA CG GC GU UG
CG 316:368 - -  6 - 19 26
339:348 - 1  - - -
GC 314:370 - - -  1 - 39
318:366 6 - -  - -
328:353 12 - 6  1 -
341:346 13 -  - -
AU 317:369  - 25 - - 1 101
322:359  - - 9 1 -
327:354  - - 36 - -
329:352  - - 27 - -
338:349  3 - - - -
UA 326:355 5  - - - - 43
340:347 6  19 13 - -
The total of each compensatory substitution types 42 3 50 91 3 20 209
a Nucleotide bases and position refer to the HRV A41 sequence (GenBank accession number DQ473491).
Table 3
Nucleotide frequencies of non-compensatory and compensatory nucleotide
substitutions
Purine–pyrimidine
frequency
Nucleotide
frequency
Non-compensatory
substitutions in SL-IVca
Purine (0.529) A: 0.129, G: 0.400
Pyrimidine (0.471) U: 0.143, C: 0.328
Only compensatory
substitutions in SL-IVcb
Purine (0.500) A: 0.229, G: 0.271
Pyrimidine (0.500) U: 0.238, C: 0.262
a A total of 31 positions in the ﬁnal dataset.
b A total of 26 positions in the ﬁnal dataset.
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GUAA, GUGA, GAGA, and GCAA, were identiﬁed in this study and
are presented in Table 4. The GCGA sequence type was the most
common type, with 58 cases (62.4%) found. Of the other types, 18
(19.3%) GUGA and 15 (16.1%) GUAA sequence types were found,
and GAGA and GCAA were identiﬁed in only one (1.1%) of them,
respectively.
4. Discussion
In this study, 194 primary sequences and secondary structures
of SL-IV, from 97 clinical isolates and 97 reference strains of HRV,
were analyzed. From the results of the 97 references in this study,
the average nucleotide sequence identity in the IRES domain was
74.66%, which was higher than the complete HRV genome average
identity of 65.87%. Palmenberg et al.34 reported this conservationTable 4
GNRA motif types in SL-IVc
Nucleotide substitutions Number (%)
Ga (342b) Nc (343) Rd (344) Aa (345)
Types of GNRA
motif
G C G A 58/93 (62.4%)
G U A A 15/93 (16.1%)
G U G A 18/93 (19.3%)
G A G A 1/93 (1.1%)
G C A A 1/93 (1.1%)
a G(342) and A(345) are conserved sequences.
b Nucleotide position refers to the HRV A41 sequence (GenBank accession
number DQ473491).
c N indicates that all sequences can be substitutions.
d R stands for either A or G purine residue.in the IRES domain relative to other regions of the HRV genome.
Among the IRES sub-domains, it was determined that the SL-IVc
region of the HRV IRES had the highest sequence identity with a
conserved (predicted) secondary structure, although many nucle-
otide substitutions in SL-IVc occurred. The predicted structures
were classiﬁed into two groups that were not consistent with
clusters based on primary sequence identities or phylogenetic
analysis, and it was hypothesized that these were the result of
compensatory substitutions. The concept of compensatory substi-
tution was introduced by Haldane and Wright in 1931, when they
reported on epistatic ﬁtness interactions, which were described as
interactions between genes with secondary structuring. Later, in
1995, Kirby et al. suggested that the compensatory evolution of
RNA structure was an example of epistatic selection.35 Compensa-
tory substitutions are observed in Drosophila rRNA, 5S rRNA, and
other gene sequences.36–42
In the present analysis, the compensatory substitution rate of
AU and UA was almost twice that of CG and GC substitutions.
Also, non-compensatory substitution nucleotides (including con-
served nucleotides, and a poly(C) loop region and a GNRA motif in
the predicted structure) showed a higher G (0.4) and C (0.329)
frequency than compensatory substitution nucleotides. Therefore,
two hydrogen bonds between an adenine–uracil pair were more
unstable than the three hydrogen bonds of a guanine–cytosine pair
in compensatory mutations.
The GNRA motif was identiﬁed in the SL-IV sequence of the type
I IRES and in SL-III of the type II IRES. This motif is believed to play
an essential role in IRES activity.9,43–46 The GNRA motif was
conserved in the sequences of 183 foot-and-mouth disease virus
(FMDV) isolates, with ﬁve common sequence types, including the
most common GUAA.46 In the present study, ﬁve HRV GNRA motif
types, GCGA, GUAA, GUGA, GAGA, and GCAA, were identiﬁed.
GCGA was the main type (62.4%) in HRV. This type was only
observed in 2.2% of FMDV isolates in the previous report.46 In 1997,
Lopez de Quinto and Martinez-Salas reported that GCGA (the
primary HRV GNRA motif identiﬁed in this study) and GUAA (the
primary FMDV GNRA motif identiﬁed in the prior study) have
equal IRES translation efﬁciencies.43 Therefore, it is expected that
while the primary GNRA form is different from that of FMDV, the
translation efﬁciency of IRES may not be reduced.
In the type I IRES, it was reported that the SL-IV region, consisting
of SL-IVa, SL-IVb, SL-IVc, and SL-IVd, has critical functions involving
host–protein interactions that facilitate the translation of viral
proteins. The IRES of poliovirus and enterovirus 71 has been found to
interact with a cysteine (aa54) of the hnRNP K homology 1 (KH1)
domain of PCBP2, and PCBP2 is known to participate in the
H. Kim et al. / International Journal of Infectious Diseases 41 (2015) 21–28 27stabilization and regulation of translation of both poliovirus and
enterovirus proteins.23,25,47,48 In an experiment with coxsackievirus,
cytosines in the poly(C) loop of SL-IVb and SL-IVc were substituted
for guanine in vitro, causing a large reduction in the interaction of the
IRES with PCBP2. Moreover, the substitution in SL-IVc had an even
greater effect than that in SL-IVb.23 In addition, the bulge structure
consisting of 364(G) and 365(G) was assumed to have a critical role
in the interaction between eIF4G and IRES, as studied in poliovirus
and enterovirus 71.47When the host proteins interact with the IRES
region of the virus genome, the physical structure and chemical
signal binding sites in the IRES also impact translation efﬁcien-
cy.9,49,50 Therefore, we suggest that the compensatory base
substitutions in the SL-IVc sub-domain of the HRV IRES satisfy
the physical structure required to maintain the IRES function. In
addition, we suggest that the 17 conserved nucleotides, the poly(C)
loop region, and the GNRA motif in this region also meet the physical
and chemical conditions needed to initiate efﬁcient translation.
However, more sequences of clinical HRV isolates from patients
exhibiting severe and mild symptoms should be analyzed and in
vitro experiments should be designed to explore the functional
impact of sequence and structural differences observed in this study.
We will continue to investigate HRV IRES functions, including its
interactions with host proteins, HRV protein translation, infection,
and drug development.
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